Solid Biosciences Inc. (SLDB:NASDAQ) jumped higher at $5.91, representing a gain of 23.4%. The stock appeared on our News Catalysts scanner on Fri 11 Dec 20 at 05:38 PM in the 'ACQUISITION' category. From Mon 30 Nov 20, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Thu 01 Oct 20 at $6.1 with a volume of 193M+.
About Solid Biosciences Inc. (SLDB:NASDAQ)
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Top 10 Gainers:
- Concord Medical Services Holdings Limited (CCM:NYSE), 179.46%
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 87.01%
- Prevail Therapeutics Inc. (PRVL:NASDAQ), 82%
- MicroVision, Inc. (MVIS:NASDAQ), 34.5%
- ELYS (ELYS:NASDAQ), 29.03%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 27.62%
- Arvinas, Inc. (ARVN:NASDAQ), 27.18%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 26.66%
- Sensus Healthcare, Inc. (SRTS:NASDAQ), 26.4%
- Solid Biosciences Inc. (SLDB:NASDAQ), 23.38%